David Moller - Dissemin

Language
Login

All papers authored by David Moller

This paper was not found in any repository, but could be made available legally by the author.

2023 Stephen A. Harrison, Carole Thang, Sébastien Bolze, Sheila Dewitt

ORCID

, Sophie Hallakou-Bozec

ORCID

, Julie Dubourg

ORCID

, Pierre Bedossa, Kenneth Cusi, Vlad Ratziu

ORCID

, Jean-Marie Grouin, David E. Moller

ORCID

, Pascale Fouqueray

Evaluation of PXL065 – deuterium-stabilized (R)-pioglitazone in patients with NASH: A phase II randomized placebo-controlled trial (DESTINY-1)

Upload

This paper is made freely available by the publisher.

2021 Sophie Hallakou-Bozec, Micheline Kergoat, Pascale Fouqueray, Sébastien Bolze, David E. Moller

ORCID

Imeglimin amplifies glucose-stimulated insulin release from diabetic islets via a distinct mechanism of action

Download from doi.org

This paper is made freely available by the publisher.

2020 Sophie Hallakou‐Bozec, Guillaume Vial

ORCID

, Micheline Kergoat, Pascale Fouqueray, Sébastien Bolze, Anne‐Laure Borel

ORCID

, Eric Fontaine

ORCID

, David E. Moller

ORCID

Mechanism Of Action Of Imeglimin – A Novel Therapeutic Agent For Type 2 Diabetes

Download from onlinelibrary.wiley.com

This paper was not found in any repository, but could be made available legally by the author.

Sophie Hallakou‐Bozec, Micheline Kergoat, David E. Moller

ORCID

, Sébastien Bolze

Imeglimin preserves islet β‐cell mass in Type 2 diabetic ZDF rats

Upload

Missing publications? Search for publications with a matching author name.